| Dr Courtney Johnson, MD, PHD | |
|
1550 Orleans St Ste 207, Baltimore, MD 21287-0014 | |
| (601) 278-4974 | |
| Not Available |
| Full Name | Dr Courtney Johnson |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 7 Years |
| Location | 1550 Orleans St Ste 207, Baltimore, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326579160 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | D92328 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
Women who fail to have adequate check-ups during pregnancy are more likely to be suffering physical violence at the hands of their partners.
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical success for patients across multiple sites using multiple operators.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for dapagliflozin, an investigational compound for the treatment of adults with type 2 diabetes mellitus.
"As many as 200 million children across the world fail to reach their full potential because their early brain development is held back by poverty, disease and malnutrition, global health experts said on Thursday," Reuters reports.
New research could shed light on the mystery cause of a lung disease that is a major killer, and potentially unlock new treatments.
› Verified 9 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Women who fail to have adequate check-ups during pregnancy are more likely to be suffering physical violence at the hands of their partners.
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical success for patients across multiple sites using multiple operators.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for dapagliflozin, an investigational compound for the treatment of adults with type 2 diabetes mellitus.
"As many as 200 million children across the world fail to reach their full potential because their early brain development is held back by poverty, disease and malnutrition, global health experts said on Thursday," Reuters reports.
New research could shed light on the mystery cause of a lung disease that is a major killer, and potentially unlock new treatments.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Courtney Johnson, MD, PHD 1550 Orleans St Ste 207, Baltimore, MD 21287-0014 Ph: (601) 278-4974 | Dr Courtney Johnson, MD, PHD 1550 Orleans St Ste 207, Baltimore, MD 21287-0014 Ph: (601) 278-4974 |
News Archive
Women who fail to have adequate check-ups during pregnancy are more likely to be suffering physical violence at the hands of their partners.
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical success for patients across multiple sites using multiple operators.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application for dapagliflozin, an investigational compound for the treatment of adults with type 2 diabetes mellitus.
"As many as 200 million children across the world fail to reach their full potential because their early brain development is held back by poverty, disease and malnutrition, global health experts said on Thursday," Reuters reports.
New research could shed light on the mystery cause of a lung disease that is a major killer, and potentially unlock new treatments.
› Verified 9 days ago
Sarah Nakib, MD, MPH Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Baltimore, MD 21287 Phone: 410-955-8662 | |
Elizabeth Tanzi, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6776 | |
Crystal Ugochi Aguh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1550 Orleans St, Crb Ii Room 211, Baltimore, MD 21287 Phone: 410-955-2400 Fax: 410-955-8645 | |
Dr. Larry H Gaston, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2300 Garrison Blvd, Suite 260, Baltimore, MD 21216 Phone: 410-945-7544 Fax: 410-945-3605 | |
Dr. Manisha J. Loss, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St, Suite 8060b, Baltimore, MD 21287 Phone: 410-502-2082 | |
Dr. Marcia Sanford Driscoll, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 419 W Redwood St, Suite 160, Baltimore, MD 21201 Phone: 410-328-3167 Fax: 410-328-1323 | |
Dr. Myriam Lucia Vega Gonzalez, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 601 N Caroline St # 8072, Baltimore, MD 21287 Phone: 410-955-5933 Fax: 410-502-2309 |